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Edited by Lukas HuberAbstract This study is to reveal the characteristics of bidirec-
tional regulation of emodin (1,3,8-trihydroxy-6-methyl-anthra-
quinone) and quercetin on gizzard smooth muscle myosin. Our
results indicate that: (a) emodin demonstrates stimulatory
eﬀects, and quercetin produces inhibitory eﬀects on myosin phos-
phorylation and Mg2+-ATPase activities of Ca2+/calmodulin-
dependent phosphorylated myosin in a dose-dependent manner;
(b) a combination of emodin and quercetin enhances phosphory-
lation and Mg2+-ATPase activities for partially phosphorylated
myosin and inhibits those activities for fully phosphorylated myo-
sin; (c) 1-(5-Chloronaphthalene-1-sulfonyl)-1H2-hexahydro-1,4-
diazepine inhibits myosin phosphorylation in the presence of
emodin and/or quercetin. A combination of emodin and quercetin
indicates its potential for modulating gastric-intestinal smooth
muscle.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Emodin (1,3,8-trihydroxy-6-methyl-anthraquinone) is a
commonly occurring anthraquinone derivative isolated from
Rheum [1], Rheum oﬃcinale Baill [2], and other traditional
Chinese medicines [3]. Emodin has been reported to signiﬁ-
cantly inhibit epidermal growth factor (EGF)-induced migra-
tion in various human cancer cell lines [4] and to exhibit an
immunosuppressive eﬀect [5].
Quercetin (3,3 0,4 0,5,7-pentahydroxyﬂavone) is a ﬂavonoid
and is found in various edible plants such as onions, apples,
grapes, wine, tea, berries, and spices. Quercetin exerts
antioxidant and antihypertensive eﬀects [6]; and at low
concentrations, quercetin exhibits anti-proliferative and anti-
inﬂammatory properties [7].Abbreviations: MLCK, myosin light chain kinase; CaM, Calmodulin;
CDPM, Ca2+/CaM-dependent phosphorylation of myosin; ML-9, 1-
(5-chloronaphthalene-1-sulfonyl)-1H2-hexahydro-1,4-diazepine
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doi:10.1016/j.febslet.2005.12.041In addition to these eﬀects, the areas of interest are de-
scribed as follows. (a) Some medicinal herbs contain both
emodin and quercetin, e.g., Aster tataricus [8], and Alpinia
oﬃcinarum [9]. (b) Both emodin and quercetin can relax vas-
cular smooth muscle [10,11]. (c) Emodin contracts intestinal
smooth muscle, and the possible mechanism has been
believed to relate to increasing [Ca2+]i and PKCa transloca-
tion, which in turn leads to the activation of myosin and
myosin light chain kinase (MLCK) and the suppression of
MLCP [12]. Emodin also has been thought to be correlated
with the triggering of the release of endogenous acetylcho-
line, which acts on muscarinic receptors to cause contraction
[13]. (d) Quercetin depresses intestinal peristalsis, and this
inhibition can be partially prevented by apamin, N-nitro-L-
arginine methyl ester, and naloxone [14]. Quercetin has also
been observed to inhibit intestinal contraction induced by
calcium, demonstrating a clear calcium-antagonistic eﬀect
[15].
Since the mechanism of smooth muscle contraction and
relaxation is related to the regulation of myosin function both
directly and indirectly [16,17], the modulation of myosin pro-
vides important indexes to evaluate the eﬀects of the modula-
tors. The purpose of our study is to compare the eﬀects of
emodin and quercetin on gizzard smooth muscle myosin in a
puriﬁed system and to reveal the possible interaction between
emodin and quercetin on myosin function.2. Materials and methods
2.1. Materials
1-(5-Chloronaphthalene-1-sulfonyl)-1H2-hexahydro-1,4-diazepine
(ML-9), and dithiothreitol (DTT) were purchased from Sigma. Ethyl-
eneglycolbis (2-aminoethy ether) tetraacetic acid (EGTA) was ob-
tained from Wako. Calmodulin (CaM) was generously provided by
Pro. K. Kohama, Gumma University, School of Medicine, Japan.
Emodin and quercetin were bought from Sigma. Dimethyl sulfoxide
(DMSO) was used to prepare 0.1% emodin and 0.1% quercetin stock
solution.
2.2. Protein puriﬁcation
MLCK used in the assay were puriﬁed from chicken gizzard smooth
muscle as described previously [18]. The puriﬁed myosin was unphos-
phorylated determined by using 10% glycerol electrophoresis.
2.3. Measurement of myosin phosphorylation
Phosphorylation of smooth muscle myosin was carried out in a
20 mmo/l Tris–HCl (pH 7.4) buﬀer containing 1 mmol/l DTT,
5 mmol/l MgCl2, 60 mmol/l KCl, 0.1 mmol/l CaCl2, 0.6 lmol/l CaM,
4 lmol/l myosin, and 2 mmol/l ATP at 25 C for 20 min. 10% glycerol
polyacrylamide gel electrophoresis (PAGE) was used to measure the
extent of phosphorylation of MLC20 [19,20].blished by Elsevier B.V. All rights reserved.
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Myosin Mg2+-ATPase activity was measured in a 20 mmol/l Tris–
HCl (pH 7.4) buﬀer containing 60 mmol/l KCl, 5 mmol/l MgCl2,
1 mmol/l DTT, 0.5 mmol/l ATP, 0.1 mmol/l CaCl2, 0.6 lmol/l CaM,
and 0.4 lmol/l myosin at 25 C for 10 min using the malachite green
method [21].
2.5. Other methods
Protein concentration was determined using the Bradford method
[22] with bovine serum as standard.
Data were analyzed by ANOVA for multiple data and Student’s t-
test for paired data, using the SSPS software. The level of statistical
signiﬁcance adopted was P < 0.05.
To analyze the percentage of MLC20 phosphorylation, Scoin Image
Software was used to scan the density and size of phosphorylated
MLC20 and calculate the percentage of phosphorylated MLC20 in total
MLC20. Mono-phosphorylation was calculated as 100% phosphoryla-
tion.Concentration of quercetin (µmol/L)
Fig. 2. Eﬀects of quercetin in diﬀerent concentrations on the Mg2+-
ATPase activities of CDPM and unphosphorylated myo-
sinðX  s; n ¼ 6Þ. Filled triangle (m) and open triangle (n) represent
CDPM and unphosphorylated myosin respectively. The Mg2+-ATPase
activity of unphosphorylated myosin is calculated as 100%. Other data
obtained from quercetin are the relative values compared to the
corresponding control (without quercetin). **P < 0.01, #P > 0.05.
Sample with quercetin vs. the corresponding controls without quercetin.3. Results
3.1. Eﬀects of emodin on myosin Mg2+-ATPase activities
Fig. 1 indicates that emodin at concentrations from 2 to
32 lmol/l induces a dose-dependent stimulation on Ca2+/
CaM-dependent phosphorylation of myosin (CDPM), but
there are no observable eﬀects on unphosphorylated myosin.
With the increase of emodin concentration to 32 lmol/l, the
maximal Mg2+-ATPase activity of CDPM reaches 215% com-
pared to the control. In the presence of actin (4 lmol/l), emo-
din (2–32 lmol/l) also exhibits a dose-dependent stimulation
on CDPM and has no observable eﬀects on unphosphorylated
myosin (data not shown).
3.2. Eﬀects of quercetin on myosin Mg2+-ATPase activities
Fig. 2 demonstrates that quercetin (2–32 lM) induces a
dose-dependent inhibition on Mg2+-ATPase activities of
CDPM and has no observable eﬀects on those of unphosphor-
ylated myosin. With the increase of quercetin concentration to0
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Fig. 1. Eﬀects of emodin in diﬀerent concentrations on the Mg2+-
ATPase activities of CDPM and unphosphorylated myosin.
ðX  s; n ¼ 6Þ Filled triangle (m) represents CDPM, and open triangle
(n) represents unphosphorylated myosin. The Mg2+-ATPase activity
of unphosphorylated myosin is calculated as 100% **P < 0.01, vs.
phosphorylated control (without emodin); #P > 0.05, vs. unphosphor-
ylated control (without emodin).32 lmol/L, the minimum Mg2+-ATPase activity of CDPM
myosin is reduced to 51% compared to the control. In the pres-
ence of actin (4 lmol/L), quercetin (2–32 lmol/L) also induces
a dose-dependent inhibition on Mg2+-ATPase activity of
CDPM, and there are no observable eﬀects on unphosphory-
lated myosin (data not shown).
3.3. Interaction of emodin and quercetin on myosin
Mg2+-ATPase activities
We have investigated the possible interaction between emo-
din and quercetin on Mg2+-ATPase activities of CDPM. Using
partially phosphorylated myosin, we have observed the follow-
ing characteristics (Fig. 3A). (a) Both emodin (Column 3) and
the combination of emodin and quercetin (Column 4) increase
Mg2+-ATPase activities of CDPM, although the potentiation
of the latter is weaker than that of the former. (b) The poten-
tiation of Mg2+-ATPase activity by emodin used alone or con-
currently with quercetin is inhibited by ML-9 (Columns 5 and
6).
Using fully phosphorylated myosin, we found the following
characteristics (Fig. 3B). (a) The concurrent use of emodin and
quercetin (Column 4) signiﬁcantly inhibits the Mg2+-ATPase
activities of CDPM, although more weakly than when querce-
tin is used alone (Column 3). (b) The inhibition of myosin
Mg2+-ATPase activity by quercetin and its concurrent use with
emodin is further strengthened by ML-9 (Columns 5 and 6).
3.4. Modulation of emodin and quercetin on myosin
phosphorylation
We have found that emodin produces a dose-dependent
stimulation of myosin phosphorylation at concentrations of
2–32 lmol/l. Quercetin (2–32 lmol/l) induces a dose-dependent
inhibition on the extent of myosin phosphorylation (data not
shown).
Fig. 4 demonstrates that, for partially phosphorylated myo-
sin, the increase of phosphorylation is observed not only with
Fig. 4. Eﬀects of emodin and quercetin on partially phosphorylated
myosin ðX  s; n ¼ 6Þ. 0.02 lmol/l MLCK and 4 lmol/l myosin (par-
tially phosphorylated) are used in the assay. (A) Glycerol PAGE. LC20,
unphosphorylated MLC20 (20 kDa regulatory myosin light chain); p-
LC20, mono-phosphorylated MLC20; pp-LC20, di-phosphorylated
MLC20; LC17, 17 kDa myosin essential light chains. Panel A describes:
unphosphorylatedmyosin (Lane0),CDPM(Lane1),CDPM+ 10 lmol/
l emodin (Lane 2), CDPM + 10 lmol/l emodin + 10 lmol/l quercetin
(Lane3),CDPM + 10 lmol/l emodin + 10 lmol/l quercetin +100 lmol/
l ML-9 (Lane 4), and CDPM + 10 lmol/l emodin + 100 lmol/l ML-9
(Lane 5). (B) The extent of myosin phosphorylation, which is analyzed
using Scoin Image Software. Mono-phosphorylation is chosen as the
control and calculated as 100%, and other data are the relative values
compared to the control. &&P < 0.01 vs. CDPM (Column 1), **P < 0.01
vs. CDPM + emodin (Column 2), ##P < 0.01vs. CDPM + emodin +
quercetin (Column3).
Fig. 3. Eﬀects of emodin and quercetin on the Mg2+-ATPase activities of myosin in diﬀerent phosphorylation states ðX  s; n ¼ 6Þ. (A) Assays are
performed using 0.02 lmol/l MLCK and 4 lmol/l partially phosphorylated myosin as described in Section 2; unphosphorylated myosin (Column 1);
CDPM (Column 2) ; CDPM + 10 lmol/l emodin (Column 3); CDPM + 10 lmol/l emodin + 10 lmol/l quercetin (Column 4); CDPM + 10 lmol/l
emodin + 100 lmol/l ML-9 (Column 5); CDPM + 10 lmol/l emodin + 10 lmol/l quercetin + 100 lmol/l ML-9 (Colomn 6). (B) Assays are performed
using 0.2 lmol/l MLCK and 4 lmol/l fully phosphorylated myosin; unphosphorylated myosin (Column 1); CDPM (Column 2); CDPM + 10 lmol/l
quercetin (Column 3); CDPM + 10 lmol/l quercetin + 10 lmol/l emodin (Column 4); CDPM + 10 lmol/l quercetin + 100 lmol/l ML-9 (Column 5);
CDPM + 10 lmol/l quercetin + 10 lmol/l emodin + 100 lmol/l ML-9 (Column 6); The Mg2+-ATPase activity of unphosphorylated myosin is 100%.
The others are the relative values compared to the Mg2+-ATPase activity of unphosphorylated myosin. &&P < 0.01 vs. Column 2, **P < 0.01 vs.
Column 3, ##P < 0.01 vs. Column 4.
Fig. 5. Eﬀects of emodin and quercetin on fully phosphorylated myosin
ðX  s; n ¼ 6Þ. The assays were performed using 0.2 lmol/l MLCK and
4 lmol/l myosin (fully phosphorylated). (A) Glycerol electrophoresis
results. Unphosphorylated myosin (Lane 0), CDPM (Lane 1),
CDPM + 10 lmol/l quercetin (Lane 2), CDPM + 10 lmol/l quercetin +
10 lmol/l emodin (Lane 3), CDPM + 10 lmol/l quercetin + 10 lmol/l
emodin + 100 lmol/l ML-9 (Lane 4), CDPM + 10 lmol/l querce-
tin + 100 lmol/l ML-9 (Lane 5). (B) The extent of myosin phosphory-
lation, which is analyzed using Scoin Image Software.
Mono-phosphorylation is chosen as the control and calculated as
100%. Other data are the relative values compared to the control.
&&P < 0.01 vs. CDPM (Column 1), **P < 0.01 vs CDPM + quercetin
(Column 2), ##P < 0.01 vs CDPM + quercetin + emodin (Column 3).
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quercetin (Lane 3), and both of the phosphorylation potentia-
tions are inhibited by ML-9 (Lanes 4 and 5). For fully phos-
phorylated myosin (Fig. 5), not only quercetin (Lane 2) but
also the combination of emodin and quercetin (Lane 3) inhibit
myosin phosphorylation. Both inhibitory eﬀects are further in-
creased by ML-9 (Lanes 4 and 5).4. Discussion
Smooth muscle contraction is activated primarily via CDPM
by MLCK featured by the enhancement of Ca2+ concentration
causing the increase of actin-activated myosin ATPase activity,
MLC20 phosphorylation, and force [23,24]. Since the changes
in myosin phosphorylation and Mg2+-ATPase activity reﬂect
the regulation myosin function, we chose them as important
indexes to determine the eﬀects of emodin and quercetin on
myosin.
Our results demonstrate four characteristics of the regulation
of emodin and quercetin on gizzard smooth muscle myosin. (a)
Emodin only exhibits stimulatory eﬀects, while quercetin only
produces inhibitory eﬀects on Mg2+-ATPase activities of phos-
phorylated myosin in a dose-dependent manner, regardless of
the absence or presence of actin. No observable eﬀects on
unphosphorylated myosin are observed for emodin and querce-
tin. These results diﬀer from some regulatory proteins, e.g., cal-
desmon and calponin acting on Mg2+-ATPase activity of
myosin; Besides activating CDPM, caldesmon and calponin
also activate Mg2+-ATPase activity of unphosphorylated myo-
sin to some extent [25,26]. (b) Emodin increases and quercetin
decreases the extent of myosin phosphorylation; Such eﬀects
are consistent with the eﬀects of emodin and quercetin on
Mg2+-ATPase activities of phosphorylated myosin. (c) Concur-
rent use of emodin and quercetin yields a bi-directional regula-
tion on both Mg2+-ATPase activities of CDPM and the
phosphorylation of myosin. Stimulatory eﬀects are observed
in partially phosphorylated myosin with 0.02 lmol/l MLCK
(Fig. 3A, Column 4, Mg2+-ATPase activity; Fig. 4, Lane 3, Col-
umn 3, myosin phosphorylation). Inhibitory eﬀects are ob-
tained for fully phosphorylated myosin using 0.2 lmol/l
MLCK, (Fig. 3B, Column 4, Mg2+-ATPase activity; Fig. 5,
Lane 3, Column 3, myosin phosphorylation). The bi-directional
regulatory eﬀects from emodin and quercetin used in combina-
tion imply that gastro-intestinal smooth muscle should not be
over contracted or over relaxed if the two agents in combination
are properly used. (d) Regardless of the extent of phosphoryla-
tion, or whether emodin and quercetin are used alone or in
combination, all the eﬀects are inhibited by ML-9, which does
not produce bi-directional regulation on myosin in our assay
condition.
As we mentioned previously, the consistent eﬀects of emo-
din and quercetin on vascular smooth muscle, the inconsistent
eﬀects on gastro-intestinal smooth muscle, and the co-exis-
tence of emodin and quercetin in the same medicinal herbs
encouraged us to conduct this investigation. We observed that
the concurrent use of emodin and quercetin on various states
of myosin phosphorylation produced diﬀerent responses.
These results provide some important information for us to
further evaluate the possible mechanism and future clinical
application of emodin and quercetin before we oﬀer any
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